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Abstract 
 
This study describes a novel fabrication method to produce a hybrid paper-based microfluidic 
platform, termed Multi-Pad Paper Plate (MP3) for transfer and optimisation of enzyme-linked 
immunoassays (ELISA) on paper (P-ELISA). The new fabrication technique is based on a combination 
of laser micromachining of paper and packaging through thermal lamination. This method is simple, 
rapid and of high-resolution and can produce robust, versatile and low-cost devices, compatible with 
a standard 96-well microplate format. The MP3 was used to transfer a sandwich ELISA for detection of 
bovine haptoglobin (Hp), a marker of inflammation in animals allowing optimisation of the assay in 
the new format. Using the MP3, a standard curve was generated and the limit of detection achieved 
was 0.73 μg/ml. The optimised protocol was also applied to the detection of Hp in bovine serum, 
demonstrating the possibility of using this platform with biological samples. The new platform allowed 
for a reduction of 93% in time and of 88% in cost for performing the assay and represents a valid 
alternative to other commonly used device fabrication methods, especially in the context of low-
resource settings. It has the potential to translate similar assays into P-ELISA and offers a starting point 
for achieving animal-side testing. 
 
1. Introduction 
 
One of the most promising technologies that have recently been applied within point-of-care (POC) 
diagnostics is microfluidics [1]. At present, two main types of microfluidic systems are used in the 
diagnostic field: micro total analysis systems (μTAS) and microfluidic paper-based analytical devices 
(μPADs). The latter, in particular, represent an appealing application for low resource settings, due to 
their low-cost and ease of fabrication. Paper is cheap, easy to source, biodegradable and simple to 
chemically modify [2]. Furthermore, POC devices made from paper have the considerable advantage 
of not requiring external power sources, whilst fabrication techniques and machinery for production 
are usually cheaper than those required for other materials [3]. Paper represents an excellent medium 
for diagnostic testing, because of its high surface to volume ratio, which allows reagents to be 
concentrated and also enables more rapid reaction times [4]. 
Within the field of μPADs, an interesting application has recently been demonstrated in the translation 
of ELISA onto paper (P-ELISA) [[4], [5], [6], [7], [8]]. P-ELISA combines the sensitivity and specificity of 
ELISA with the intrinsic low cost and ease-of-use of paper-based platforms [9]. There are increasing 
numbers of studies reporting the use of paper ELISA as a valid alternative to the conventional format 
[6,7,10]. The most commonly used methods for fabrication of these platforms are photolithography 
[10] and wax printing techniques [6,8,11]. The main drawbacks are the numerous steps involved for 
production of the final device [4], the cost of the use of photoresist [12], poor channel resolution [12] 
and the lack of resistance to sustain high temperature. To overcome these limitations a new concept 
of low-cost device has also been introduced, called paper hybrid microfluidic platforms [13]. A 
combination of paper and other materials, like PMMA [14], PDMS [15], cotton [16] or glass [17] are 
combined to fully exploit the properties of each material [13], reducing the limitations and drawbacks 
of the previous techniques. However, the current fabrication methods are still limited by the speed of 
prototype devices and high cost for scalable manufacturing. 
Within veterinary diagnostics, the use of haptoglobin (Hp) as a marker of disease status has recently 
attracted considerable attention [[18], [19], [20], [21], [22]]. Hp is classified as a serum biomarker, one 
of a number of acute phase proteins which increases rapidly following infection or inflammation, 
providing a quantification of tissue damage in a diseased animal [23]. Hp is normally present in the 
serum of healthy cattle in concentrations <0.02 mg/ml [24], but a level rise above 25% of the normal 
circulating level is usually indicative of a diseased status [25]. Measurement of Hp in bovine serum is 
currently available with laboratory-based assays, either through a colorimetric reaction based 
on peroxidase activity of the haptoglobin-haemoglobin complex or with a commercially available 
ELISA kit [26]. Furthermore, Hp standards are commercially available making this assay the ideal 
candidate for transfer to the P-ELISA system. It is also a very relevant assay for investigation into future 
POC or “animal-side” diagnostics as the possibility of detecting the level of Hp at the POC, will allow 
for disease to be diagnosed in a timely and cost-effective manner, improving overall animal health and 
welfare [27]. 
This study describes a novel fabrication method for realisation of a hybrid paper-based microfluidic 
platform, termed multi-pad paper plate (MP3), which can produce a device compatible with standard 
96-well microplate format allowing rapid and low-cost translation and optimisation of laboratory-
based ELISA assay into P-ELISA. The model used for the translation and optimisation of a laboratory-
based assay using this platform is reported and is based on the development of a standard curve for 
detection of haptoglobin. The optimised protocol was further tested by analysing bovine serum 
samples with known Hp concentrations and by comparing results with the existing laboratory-based 
ELISA. 
 
2. Experimental 
 
2.1. MP3 design and fabrication 
 
The MP3 was fabricated using a laser micromachining of paper and thermal lamination technique. A 
3D mechanical computer-aided design (CAD) (SolidWorks 2012, USA) was used to design both the 
paper device and the plastic lamination used for device packaging (Fig. 1). Whatman Grade 1 (WHT 1) 
cellulose chromatography paper (Sigma-Aldrich, UK) and 75μ gloss laminating pouches (Staples, UK) 
were cut using a class 2 CO2 laser (Speedy 300 Laser Engraver - Trotec). The optimised settings for 
cutting both materials were: power 4%, speed 0.4, PPI/Hz 1000, passes 1, air assist on. These settings 
were chosen as the best combination for fast and precise production, while avoiding material burning. 
A range of settings were evaluated to achieve the high resolution required, while maintaining fast 
production (minimum time possible for fabrication) and ease of removal of devices (both paper and 
lamination sheets not requiring manual trimming or tearing). Increasing power settings to above 4% 
(i.e. 0.16 W) was associated with burning (darkening) of the paper edges, while below the 4% 
threshold there was incomplete cutting of the material. When the speed was increased to 0.6, paper 
had to be manually detached from the main sheet, with high risk of tearing the microchannels 
(0.5 mm) and making the device not usable. 
 
Figure 1 Schematic of the fabrication of the MP3. A) Paper cut with a laser cutter. B) Laminating pouches cut with a laser 
cutter. C) Assembly of device in the pre-cut lamination sheets. D) Lamination of the device. E) Severing of interconnecting 
paper channels by laser cutter. F) Application of two different food colours (red and yellow) to the device with no evidence of 
cross-contamination between pads. Numbers represent volume of fluids applied (μl). 
 
Paper and lamination sheets were cut in the desired format and then laminated to produce the final 
device. The MP3consists of 96 circular paper pads of 6 mm diameter connected by a channel of 0.5 mm 
width and 3 mm in length (Fig. 1A) and a complementary lamination sheet of 96 circular holes of 4 mm 
diameter (Fig. 1B), assembled in the pre-cut lamination sheet (Fig. 1C) and laminated at 110 °C at the 
lowest speed setting (Fig. 1D) using a roll laminator (GBC Catena 35 Roll Laminator). After lamination, 
the laminated MP3 was placed back into the laser and the connecting microchannels between pads 
were severed by the laser cutter (Fig. 1E), making each pad completely independent from the others. 
During this final step of fabrication, plate information including numbers, letters and other 
information were cut or engraved on the final device. Optimisation was also carried out for this 
second cutting process. To keep the same power and speed settings already optimised, a second cut 
(passes 2) was necessary to completely severe the channels without requiring additional manual 
handling. 
The final device was tested with food colour (Morrison Natural Food Colouring Blue) for determination 
of the optimum volume of liquid to allow complete wetting of each pad (Fig. 1F). Alterations to the 
CAD design by scaling down pad and channel dimensions as well as by introducing different areas for 
cutting, allowed for immediate variation of the MP3 platforms produced. 
2.2. Translation and optimisation of a lab-based assay into a P-ELISA 
 
Translation of the protocol was achieved by evaluating and comparing different variables for each of 
the assay parameters (Table 1) on the MP3. In order to obtain the best possible signal with the 
minimum volume and concentration of reagents, a suitable timing for the immunoreactions and a 
functional washing technique were optimised. Signal intensity was measured by scanning the 
MP3using a desktop scanner (Perfection V350 photo, Epson, UK, set to “color photo scanning”, 1200 
dpi resolution) and images were transformed in 8-bit greyscale with PixBuilder Studio 2.2 (WnSoft 
Ltd., UK). Mean gray value (mean pixel intensity) was measured with Image J (1.48v, National Institute 
of Health, USA), after image inversion and after oval selection of the area to be measured. Variables 
which provided the strongest signal (highest pixel intensity) and the lowest background noise were 
selected. 
 
Table 1 Assay parameters assessed to optimise the P-ELISA (in chronological order of evaluation). Text in bold represents the 
variables with the strongest signal (highest pixel intensity) and the lowest background noise. 
Assay parameters  Variables  
Conjugate antibody dilution 1:500 1:750 1:1000 
Number of washes 2 3 4 
Washing with absorbent pad underneath MP3 Yes No  
Washing vacuum pressure −10 Pa −30Pa −50 Pa 
Amount of washing 20μl 50μl 100 μl 
Conjugate antibody incubation time 60s 90s 150s 
Hp incubation time 5min 10min 15min 
Capture antibody dilution 1:500 1:1000 1:2000 
Capture antibody incubation time 5min 10min 15min 
 
2.3. Sandwich Hp P-ELISA protocol 
 
Based on the translation and optimisation of the lab-based protocol, a sandwich P-ELISA for the 
detection of bovine Hp was applied to the MP3. Purified rabbit anti-bovine haptoglobin IgG (Life 
Diagnostics, USA; Catalogue No. 18120) was diluted to 1:1000 in wash buffer [WB (0.02 M Tris-HCl 
with 0.05% Tween-20, pH 7.4)]. A volume of 2 μl of the prepared solution was deposited onto each 
pad and the paper allowed to dry at room temperature (RT) for 10 min. Non-specific binding was 
limited by the addition of 2 μl of blocking buffer [BB (10% (w/v) Marvel milk protein in WB)] followed 
by air drying at RT for 10 min. Standard bovine haptoglobin (0.93 mg/ml, Life Diagnostics Inc., USA) 
was diluted 1:5 in WB and then double diluted; 2 μl of neat Hp and of each dilution were deposited 
onto the pads (sequentially in each column) and allowed to react for 10 min at RT. Plates were washed 
with 100 μl WB by placing the plate in a 96 well plate vacuum manifold (Bethesda Research 
Laboratories, UK) connected to a vacuum pump (Millipore Chemical Duty Vacuum/pressure Pump, 
115 V/60 Hz, UK), with an absorbing pad made from Whatman Grade 1 cellulose chromatography 
paper (Sigma-Aldrich, UK) placed underneath the plate. After filling all wells of the manifold, the 
vacuum was activated (−10 Pa) and remained on until all wash buffer was cleared from the wells. This 
procedure was repeated three times. The purified rabbit anti-bovine haptoglobin IgG was conjugated 
with alkaline phosphatase (Lightning-Link™ Alkaline Phosphatase Conjugation Kit, Innova biosciences, 
Cambridge, UK; Catalogue No. 702-0010) according to the manufacturer’s instructions then diluted 
1:750 in WB. A volume of 4 μl was then deposited onto each pad of the paper plate and incubated at 
RT for 90 s. Plates were washed as described above. A volume of 4 μl of ready-to-use buffered alkaline 
phosphatase substrate solution (BCIP®/NBT Blue Liquid Substrate System for Membranes by Sigma-
Aldrich (Catalogue No B3804)) was added to each pad. After 10 min at RT, the paper plates were 
scanned and analysed as described in 2.2. 
To evaluate the performance of the MP3 with biological samples, bovine serum samples with known 
levels of Hp were also analysed using the MP3 and the optimised sandwich Hp ELISA protocol (Fig. 2) 
and compared with results obtained from the same samples by a standard lab-based ELISA. A total of 
8 blood samples, sourced from clinically healthy lactating cattle from a commercial dairy farm but 
showing a variable range of circulating Hp, were analysed at a 1:10 dilution in WB, in triplicate on two 
separate MP3 devices. 
 
Figure 2 Schematic representation of the sandwich Hp P-ELISA for the detection of Hp in bovine serum as applied to the MP3. 
A) Deposition of 2 μl rabbit anti-bovine IgG diluted 1:1000 in WB. B) Blocking with 2 μl BB. C) Deposition of 2 μl standard Hp 
diluted 1:20 then double diluted to 1:1280 and 2 μl bovine serum sample diluted 1:10 D) After washing, addition of 4 μl 
conjugate diluted 1:750 in WB. E) After washing, addition of 4 μl substrate. F) MP3 scanned using a flatbed desktop scanner. 
All steps of the assay were performed at room temperature. 
 
3. Results 
 
3.1. MP3 production and application 
 
Following the method described, it was possible to produce a platform with 96 completely 
independent circular pads, which was compatible with instruments commonly used in laboratories for 
96 well microplates (Fig. 3A). There was no evidence of leakage between pads, even when excess fluid 
(50 μL) was deposited. A volume of 2 μl was determined as the ideal amount to obtain complete 
wetting of the pads whilst minimising the drying time required at room temperature. The total time 
to produce one A4 sheet containing 3 devices was under 10 min, with a resolution of fabrication 
technology to 0.5 mm channels (Fig. 3B). Furthermore, precise laser cutting of 3.5*0.5 mm square 
holes between interconnected channels was achieved, by calculated alignment of the laser pointer 
with the produced device. This second laser cutting process also allowed for pre-designed numbers 
and characters to be included in the final device (Fig. 3B). The thickness of each device was 0.3 mm, 
with up to 50 MP3occupying the same space as a standard 19 mm height 96-well microplate. 
 
Figure 3 MP3 applications and production techniques. A) Colour application on MP3 using multichannel pipette. B) 
MP3 showing precise paper cutting of channels and final device engraving with letters and numbers. C) MP3 showing removal 
of the interconnecting microchannels at every 4th column to include 3 different types of paper on the same device. D) Modified 
MP3 with 96 central pads of 3 mm radius each connected to 4 smaller test zones of 2 mm radius and connecting channels of 
1 mm. Application of two different food colours (10 μl red and blue food colour dye) showed each test zone to be independent 
with solution expanding to the entire test zone, without cross-contamination of the adjacent areas. 
Through the alterations of the CAD design, it was also possible to produce two modified versions of 
the MP3. By removing the interconnecting microchannels at every 4th column (Fig. 3C) an alternative 
version allowed the inclusion of three different paper types in a single device (providing 12 
independent pads per paper type). This allowed WHT 1, Whatman filter paper Grade 4 (pore size 20–
25 μm) and Whatman filter paper Grade 597 (pore size 4–7 μm) to be included on the same device. A 
different version of the MP3, comprising 480 pads, was also produced by having each of the 96 central 
pads connected with 4 microchannels (1 mm x 0.72 mm) to 4 smaller pads (2 mm diameter), to allow 
for multiple tests to be run at the same time on the same sample (4 tests/sample) (Fig. 3D). 
3.2. Sandwich Hp P-ELISA 
 
Using the MP3, a sandwich Hp P-ELISA was successfully performed, demonstrating that increasing 
concentrations of bovine standard Hp resulted in increasing intensity responses, based on a 
colorimetric reaction and visible with the naked eye (Fig. 4A). Average pixel intensity values for each 
circular pad were analyzed in GraphPad Prism 5 (GraphPad Software, Inc., USA) and correlated with 
the different concentrations of Hp. A standard curve was generated using non-linear regression and a 
sigmoid curve response (variable slope) was obtained (Fig. 4B), showing high correlation between pixel 
intensity and Hp concentration (R2 = 0.85). The limit of detection (LOD) achieved was 0.73 μg/ml, 
calculated as three times the standard deviation of the negative control sample. Plateau of the signal 
intensity was found at an Hp concentration of 23.25 μg/ml. 
 
Figure 4 Sandwich Hp ELISA on MP3. A) Column 1–11 double dilution of Hp (1 = 930 μg/ml to 11 = 0.36 μg/ml) and 12 negative 
control (WB). Rows A to H replicates (n = 8). B) Non-linear regression (variable slope) of mean pixel intensity in relation to Hp 
concentration (μg/ml). Each data point represents the mean of 8 replicate of Hp measurements, shown as 10 logarithmic 
conversion of Hp concentration. Error bars represent standard deviation. Linear range 0.73–23.25 μg/ml. 
The levels of Hp in clinical blood samples were also assessed with the optimised P-ELISA on the 
MP3 and compared using Pearson correlation to those obtained from the standard lab-based ELISA 
protocol. There was a significant correlation (p < 0.05) between the average measurements obtained 
from the lab-based ELISA and the MP3 P-ELISA. Hp values (μg/ml) calculated from the average OD 
measurements from each sample were also compared using a paired t-test, showing that there was 
no difference (p = 0.75) between values obtained with the lab-based ELISA and the P-ELISA performed 
on the MP3 (Fig. 5). 
 Figure 5 Levels of Hp (μg/ml) in clinical blood samples calculated from the results obtain by the lab-based assay and the P-
ELISA on the MP3. 
3.3. Cost-benefit analysis of MP3 sandwich Hp P-ELISA 
The total time required to perform a complete P-ELISA on the MP3 was just over 40 min and multiple 
assays (up to 3) could be processed at the same time. The time and cost for performing the sandwich 
Hp P-ELISA was considerably reduced when compared to the same assay performed in the traditional 
lab-based format, where reductions of 88% in cost and 93% in time where achieved (Table 2). A cost 
per sample of £0.13 (when samples were run in duplicate on each device) was calculated versus a cost 
of £1 per sample for the standard lab-based ELISA. 
Table 2 Cost-benefit analysis of performing the sandwich Hp ELISA on the MP3 or with the lab-based technique. # negligible 
cost. 
 
Hp P-ELISA on MP3 
Lab-based Hp ELISA 
 Volume 
(μL) 
Time 
(min) 
Cost per 
plate 
Volume 
(μL) 
Time 
(min) 
Cost per 
plate 
Primary antibody 2 10 £1 100 480 £5.5 
Blocking buffer 2 10 # 200 60 # 
Antigen (Hp) 2 10 £1.2 100 60 £15 
Conjugated 
antibody 
4 1.5 £3.4 100 60 £20 
Substrate 4 10 £0.4 100 10 £10.5 
Plate – – £0.3 – – £1.5 
Total 14 41.5 £6.3 600 670 £52.5 
 
To translate and optimise the lab-based ELISA onto P-ELISA a total of 62 MP3where used, which 
represent a cost of translation just below £400. To obtain the standard curve a total of 6 MP3 where 
used and a further 10 MP3 where used to apply the Hp with serum. 
 
4. Discussion 
 
Here we describe a novel fabrication method to create a hybrid paper-based microfluidic device. The 
device generated, termed multi-pad paper plate (MP3) has proven to be low-cost, rapid and simple to 
produce and can be used in serological testing via ELISA. Some of the main limitations of other 
techniques available (e.g. cumbersome production and low-resolution technique) have been resolved, 
whilst offering a very robust platform (which can sustain vacuum pressure, high volumes of fluid and 
high temperatures) and a very flexible fabrication method (with the possibility of engraving/cutting of 
desired information on the device, incorporation of different materials and modification of the initial 
design for multiplex analysis). A laser cutter and a laminator are required, but no other specialised 
machinery or clean room facility are needed. Class 2 laser cutters are easily available within 
Universities and are often employed for other paper device fabrication methods, where masks or 
other devices are usually needed [4,28,29]. Computer-controlled knife plotters have also been used 
for production of paper-based devices by paper cutting, but three sequential overlapping cuts where 
required to precisely cut the chromatography paper without tearing [30]. Although a professional 
laser machine was employed in this case, commercially available CO2 laser cuttingmachines could 
potentially be used, which have a similar price to solid-ink printers, commonly used for wax printing 
of paper-based devices. Furthermore, the wax printing technique lacks the high resolution achieved 
by other methods [7], due to the wax spreading by capillary action [31]. In this case, dimensions are 
the same from design to production of the final device and a resolution of 500 μm (Fig. 3B) could be 
achieved. Although precision may not be the priority for P-ELISA platforms, it is the case for more 
complicated designs, like 3D paper-based devices. Moreover, wax is soluble in organic compounds, 
which would have made this platform unsuitable for assays in which reagents are solubilised 
in urea [32]. This method also eliminates the need for chemical treatments, which can pose health 
and safety issues and increase the overall costs of fabrication. Furthermore, lamination affords extra 
strength to the device, making it especially robust but still manageable. At the same time, correct 
assembly techniques can sometimes be an issue with these devices, therefore the use of a matrix of 
interconnecting microchannels between pads, a complete novel approach in the fabrication of these 
devices, allowed for easy and rapid device assembly, minimising inter batch differences and reducing 
wastage. 
Another considerable advantage of this system, compared to other methods, is the high degree of 
flexibility when designing a new device. Different prototypes can be created from easily made 
alterations to the original CAD file, without requiring purpose-built devices (e.g. masks), which allows 
for different conditions and/or parameters to be tested in a cost and time efficient manner. Paper of 
different pore sizes could be assembled on the same device, allowing optimisation of performance 
factors such as flow rate and reaction time or for developing immunoassays that require different 
conditions to be carried out at the same time, with the possibility of enhancing functionality. It also 
gives the possibility of using different materials on the same device, as other materials have sparked 
much interest in the field of low-cost POC devices [16]. Others have already shown the advantages in 
combining paper and cotton to reduce cross-contamination of samples [16] and the recently 
characterised class of hybrid paper microfluidic platforms show that paper could solve some of the 
intrinsic limitations of other substrates [17]. Combining different materials to enhance the 
performance of microfluidic platforms is showing favourable results in improving operator control 
over specific assay variables [33]. Due to the superior strength of the device provided by the 
lamination, it was possible to apply vigorous washing through a vacuum manifold (up to −50 Pa), which 
reduced washing time and allowed greater control over other variables, as there is less operator 
variability between plates than by standard pipette washing and removal of wash buffer through 
tapping out onto absorbent paper towels. High volumes of fluid (up to 100 μl) could also be applied 
to the device without cross-contamination or damage. 
As the spatial distances between the circular pads were maintained, as in the traditional plastic 96-
well microplate format, common instruments used in the lab (e.g. multichannel pipettes and washing 
manifolds) can also be used with the new format. This allows the platform to be used for translation 
and optimisation of a laboratory-based ELISA into P-ELISA, using a model assay for determination of 
bovine Hp in serum. The results showed that it was possible to transfer the assay onto the paper 
format with considerable reductions in both assay time and cost. The colorimetric reaction generated 
on paper demonstrated that the colour intensity was proportional to the dilution of Hp, with semi-
quantitative detection being possible using an Hp calibration curve. The colour intensity was analysed 
using a desktop scanner, however a future development could incorporate the use of a mobile 
smartphone camera to reduce reliance on bulky machinery which would not suit the definition of POC 
[34]. It could also involve the use of an app to assist in analysis and interpretation of the test outcome 
at the animal side, with the possibility for data storage. The linear range achieved was 0.73–
23.25 μg/ml and based on the expected level of Hp below 0.02 mg/ml for healthy cows [24], a sample 
dilution of 100-fold would be below the LOD for clinically healthy animals. Cases of mastitis have 
shown to be above 0.74 mg/ml [24], which at the 100-fold dilution would fall within the detectable 
range. The MP3 was able to detect different levels of Hp in biological samples (serum), with significant 
correlation between results obtained from a lab ELISA and the same ELISA performed on the MP3. Of 
the 8 samples analysed, 6 showed comparable results between the two assays, while two (sample 
2357 and 2362) had lower signal than the lab-format results. Further work is currently being 
undertaken to compare the values obtained using the lab-assay and the P-ELISA for evaluation within 
clinical settings. While the LOD achieved was 100-fold above that achievable in a commercial lab-
based ELISA (7.8 ng/ml1) this may not necessarily represent a constraint to its use in veterinary 
diagnostics, where emphasis is placed more on the achievement of cost-effective, high throughput 
and rapid testing. While the present format cannot be considered as truly POC, the possibility remains 
to use it within veterinary clinics or within remote labs, as timing is considerably reduced and the 
materials can be sold in a kit format (with packaging of 50 MP3in the space occupied by a single 
standard 96-well microplate). Furthermore, biomarkers of disease such as acute phase proteins 
usually need to be coupled with other specific disease tests or require other APPs to accurately 
determine disease status [35]. Therefore, using a modification of this platform (Fig. 3D), other 
biomarkers (up to 4/sample) of veterinary interest could be translated onto P-ELISA, in a multiplex 
format, making the transition from the lab-based to the paper format both time-efficient and cost-
effective and allowing for multiple tests to be run in parallel. 
This technique also offers the possibility of having built-in information, without the need for changes 
to the original design (Fig. 3B). A custom-made device could be built, where specific information (e.g. 
farm holding/animal number or disease to be tested) are added, upon request, to the basic platform. 
This could minimize end-user input (information the operator must add manually) and operator error 
(no need for hand writing of information). Furthermore, due to the high melting point of laminated 
sheets (devices can sustain laminating temperatures of 110 °C), the use of this platform would be 
suitable in high temperature settings (e.g. no restriction on the storage of the device at tropical/sub-
tropical ambient temperature). 
Although the technology is, at the moment, suitable specifically for laboratory prototyping, future 
high-throughput industrial manufacturing could be envisaged. A digital laser cutter and laminating 
machine, like those used in the label making industry, could be employed. Combining the two 
fabrication processes in a single machine would decrease the total production time, as well as manual 
operations to a minimum. More devices per sheets could also be produce by using larger paper sheets 
(i.e. A0). In the context of low-resource settings, a capture-antibody pre-loaded stack of devices with 
clear instructions and reference charts for colour comparison could be prepared and sent to remote 
labs for on-site testing by untrained personnel. The platform could also be used to translate other 
assays into the paper format, following the same systematic approach presented here and therefore 
increasing the scope of diagnostic tests available. 
 
5. Conclusions 
 
In conclusion, the fabrication technique developed here is a valid alternative to produce platforms 
used to perform P-ELISA previously described. The new method of production is simple, rapid and of 
high-resolution and can produce robust, versatile and low-cost devices, providing 96 completely 
independent paper pads and compatible with standard laboratory microplates and instruments. 
Furthermore, there was a reduction of 93% in time and of 88% in cost of performing a diagnostic assay. 
The method is well suited for accessible fabrication of lab prototyping devices for rapid optimisation 
of assay conditions, which could potentially be used to transfer any type of existing ELISA into P-ELISA. 
Additionally, the manufacturing method is also scalable for high volume manufacturing, producing 
large quantities of paper based microfluidic devices for POC applications as well as particularly 
suitable for low-resource settings. While it cannot be considered a POC device at this stage, it still 
offers the opportunity to carry out testing “in-house” (e.g. within veterinary clinics) due to the 
considerably reduced assay time, reagent costs and reliance on limited infrastructure. Further studies 
will focus on the evaluation of the analytical performance of the Hp P-ELISA, toward its use as 
diagnostic test in clinical settings, as well as looking at exploiting this new fabrication technique to 
develop a 3D μPAD to enable true POC testing at the “animal-side”. 
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